Intelligence Platform

Patents

Browse 793 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8980902

Poly (ADP-ribose) polymerase (PARP) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969292

High affinity leptins and leptin antagonists

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969406

Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for s

China Medical University · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969359

Gyrase and topoisomerase IV inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962685

Creatine oral supplementation using creatine hydrochloride salt

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8961993

Method of treating retinitis pigmentosa

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962561

Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-rel

The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946271

Water soluble furoxan derivatives having antitumor activity

HUMANITAS MIRASOLE S.P.A. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946455

Semi-synthetic small molecules for the treatment parasitic disease

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8946300

Use of rasagilline for the treatment of restless legs syndrome

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8937053

Process for the preparation of prasugrel and several novel crystalline forms of prasugrel

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8932588

Treatment of cancer involving mutated KRAS or BRAF genes

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8932561

Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast

Lutonix, Inc. · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916566

Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

Takeda Pharmaceutical Company Limited · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912326

Process of making gyrase and topoisomerase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912142

Method of regulating proliferation and differentiation of keratinocyes

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911743

Haemophilus parasuis polypeptides and methods of use

Regents of the University of Minnesota · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883448

Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883841

Oncogenic ras-specific cytotoxic compound and methods of use thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865686

Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865230

Compositions and methods for treating parasitic infections

TYRATECH, INC. · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846713

Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841350

Method for inducing UDP-glucuronosyltransferase activity using pterostilbene

The Regents of the University of California · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828722

Isolated populations of renal stem cells and methods of isolating and using same

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted